These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Recent progress in mycobacteriology]. Okada M; Kobayashi K Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602 [TBL] [Abstract][Full Text] [Related]
23. Identification of glucosyl-3-phosphoglycerate phosphatase as a novel drug target against resistant strain of Mycobacterium tuberculosis (XDR1219) by using comparative metabolic pathway approach. Uddin R; Zahra NU; Azam SS Comput Biol Chem; 2019 Apr; 79():91-102. PubMed ID: 30743161 [TBL] [Abstract][Full Text] [Related]
24. Designing novel possible kinase inhibitor derivatives as therapeutics against Mycobacterium tuberculosis: An in silico study. Shahbaaz M; Nkaule A; Christoffels A Sci Rep; 2019 Mar; 9(1):4405. PubMed ID: 30867456 [TBL] [Abstract][Full Text] [Related]
25. Probing the structure of Mycobacterium tuberculosis MbtA: model validation using molecular dynamics simulations and docking studies. Maganti L; Open Source Drug Discovery Consortium ; Ghoshal N J Biomol Struct Dyn; 2014; 32(2):273-88. PubMed ID: 23527569 [TBL] [Abstract][Full Text] [Related]
26. Development of potential proteasome inhibitors against Tyagi R; Srivastava M; Jain P; Pandey RP; Asthana S; Kumar D; Raj VS J Biomol Struct Dyn; 2022 Mar; 40(5):2189-2203. PubMed ID: 33074049 [TBL] [Abstract][Full Text] [Related]
27. Repurposing of antibacterial compounds for suppression of Kumar GS; Dubey A; Panda SP; Alawi MM; Sindi AA; Azhar EI; Dwivedi VD; Agrawal S J Biomol Struct Dyn; 2024 Aug; 42(13):6850-6862. PubMed ID: 37551014 [TBL] [Abstract][Full Text] [Related]
28. Molecular dynamics simulation and binding free energy studies of novel leads belonging to the benzofuran class inhibitors of Mycobacterium tuberculosis Polyketide Synthase 13. Cruz JN; Costa JFS; Khayat AS; Kuca K; Barros CAL; Neto AMJC J Biomol Struct Dyn; 2019 Apr; 37(6):1616-1627. PubMed ID: 29633908 [TBL] [Abstract][Full Text] [Related]
29. Identification of potential Mycolyltransferase Ag85C inhibitors of Mycobacterium tuberculosis H37Rv via Virtual High Throughput Screening and Binding free energy studies. Pant R; Joshi A; Maiti P; Nand M; Pande V; Chandra S J Mol Graph Model; 2020 Jul; 98():107584. PubMed ID: 32200279 [TBL] [Abstract][Full Text] [Related]
30. In silico docking and molecular dynamics simulation of 3-dehydroquinate synthase (DHQS) from Mycobacterium tuberculosis. Isa MA; Majumdhar RS; Haider S J Mol Model; 2018 May; 24(6):132. PubMed ID: 29752576 [TBL] [Abstract][Full Text] [Related]
31. Identification of novel multitarget antitubercular inhibitors against mycobacterial peptidoglycan biosynthetic Mur enzymes by structure-based virtual screening. Kumari M; Subbarao N J Biomol Struct Dyn; 2022 Nov; 40(18):8185-8196. PubMed ID: 33826470 [TBL] [Abstract][Full Text] [Related]
32. Inhibitor binding studies of Mallavarapu BD; Abdullah M; Saxena S; Guruprasad L J Biomol Struct Dyn; 2019 Sep; 37(14):3751-3763. PubMed ID: 30239262 [TBL] [Abstract][Full Text] [Related]
33. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship. Tomioka H Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755 [TBL] [Abstract][Full Text] [Related]
34. Screening of Anti-mycobacterial Phytochemical Compounds for Potential Inhibitors against Mycobacterium Tuberculosis Isocitrate Lyase. Tiwari A; Kumar A; Srivastava G; Sharma A Curr Top Med Chem; 2019; 19(8):600-608. PubMed ID: 30836915 [TBL] [Abstract][Full Text] [Related]
35. Computer-assisted discovery of safe and effective DprE1/ aaRSs Inhibitors against TB utilizing Drug Repurposing approach. Imran M; Abida ; Alotaibi NM; Thabet HK; Alruwaili JA; Asdaq SMB; Eltaib L; Kamal M; Alshammari ABH; Alshammari AMA; Alshehri A J Infect Public Health; 2023 Apr; 16(4):554-572. PubMed ID: 36812878 [TBL] [Abstract][Full Text] [Related]